MX346961B - Formulaciones farmaceuticas que contienen corticosteroides para la administracion topica. - Google Patents
Formulaciones farmaceuticas que contienen corticosteroides para la administracion topica.Info
- Publication number
- MX346961B MX346961B MX2013005764A MX2013005764A MX346961B MX 346961 B MX346961 B MX 346961B MX 2013005764 A MX2013005764 A MX 2013005764A MX 2013005764 A MX2013005764 A MX 2013005764A MX 346961 B MX346961 B MX 346961B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical formulations
- topical administration
- formulations containing
- containing corticosteroids
- corticosteroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45833910P | 2010-11-22 | 2010-11-22 | |
| PCT/US2011/059861 WO2012087443A1 (en) | 2010-11-22 | 2011-11-09 | Pharmaceutical formulations containing corticosteroids for topical administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013005764A MX2013005764A (es) | 2013-06-28 |
| MX346961B true MX346961B (es) | 2017-04-06 |
Family
ID=46064916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013005764A MX346961B (es) | 2010-11-22 | 2011-11-09 | Formulaciones farmaceuticas que contienen corticosteroides para la administracion topica. |
Country Status (20)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
| CN103705440B (zh) * | 2012-10-08 | 2017-05-10 | 天津金耀集团有限公司 | 一种哈西奈德乳膏 |
| CN103705441B (zh) * | 2012-10-08 | 2017-06-23 | 天津金耀集团有限公司 | 一种丙酸倍氯米松乳膏 |
| US20140112959A1 (en) | 2012-10-18 | 2014-04-24 | MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite | Topical steroid composition and method |
| US10111956B2 (en) | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
| CN104095805B (zh) * | 2014-01-02 | 2016-08-24 | 江苏知原药业有限公司 | 地奈德乳膏及其制备方法 |
| US20160184431A1 (en) * | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| AU2016279801B2 (en) * | 2015-06-18 | 2021-09-09 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| US20190133943A1 (en) * | 2015-06-18 | 2019-05-09 | Valeant Pharmaceuticals North America | Topical compositions and methods for treating skin diseases |
| CN106474052B (zh) * | 2016-12-16 | 2019-10-25 | 重庆华邦制药有限公司 | 二丙酸阿氯米松乳膏及其制备方法 |
| US11311482B2 (en) | 2017-05-12 | 2022-04-26 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| US10653656B2 (en) | 2018-04-05 | 2020-05-19 | Bausch Health Ireland Limited | Topical pharmaceutical compositions for treating skin conditions |
| CA3133174A1 (en) | 2019-03-14 | 2020-09-17 | Crescita Therapeutics Inc. | Rinse-off compositions and uses thereof for delivery of active agents |
| WO2021162796A1 (en) * | 2020-02-11 | 2021-08-19 | Taro Pharmaceutical Industries Ltd. | Compositions comprising desoximetasone and tazarotene |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU75903A1 (US20080070878A1-20080320-C00003.png) | 1976-09-29 | 1978-05-16 | ||
| NL7105591A (en) | 1971-04-24 | 1972-10-26 | Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4- | |
| DE2655570A1 (de) | 1975-12-12 | 1977-06-16 | Ciba Geigy Ag | Neue polyhalogensteroide und verfahren zu ihrer herstellung |
| US4048310A (en) | 1976-02-24 | 1977-09-13 | E. R. Squibb & Sons, Inc. | Topical steroid formulation in form of lotion or cream |
| US4083974A (en) | 1977-03-07 | 1978-04-11 | The Upjohn Company | Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether |
| JPS5850964B2 (ja) * | 1978-03-07 | 1983-11-14 | 東興薬品工業株式会社 | ステロイド含有クリ−ム製剤およびその製造方法 |
| US4299828A (en) * | 1979-05-31 | 1981-11-10 | E. R. Squibb & Sons, Inc. | Corticosteroid stick formulations |
| AU5794680A (en) | 1979-05-31 | 1980-12-04 | E.R. Squibb & Sons, Inc. | Corticosteroid stick formulations |
| US4233295A (en) | 1979-05-31 | 1980-11-11 | E. R. Squibb & Sons, Inc. | Corticosteroid formulations containing sebacate carrier |
| CH649923A5 (de) * | 1980-10-06 | 1985-06-28 | Glaxo Group Ltd | Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide. |
| JPS58225009A (ja) | 1982-06-23 | 1983-12-27 | Shionogi & Co Ltd | コルチコステロイド外用製剤 |
| DE3225848A1 (de) | 1982-07-07 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Kortikoidhaltige zubereitung zur topischen applikation |
| US4552872A (en) | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| GB8401965D0 (en) | 1984-01-25 | 1984-02-29 | Beecham Group Plc | Composition |
| JPH0764734B2 (ja) * | 1986-03-17 | 1995-07-12 | 大正製薬株式会社 | 経皮投与製剤 |
| CA1303991C (en) | 1986-03-31 | 1992-06-23 | Chung H. Cheng | Composition and method for delivering a steroid active ingredient |
| JPS62238216A (ja) * | 1986-04-03 | 1987-10-19 | Otsuka Pharmaceut Factory Inc | ステロイドクリ−ム製剤 |
| US5019569A (en) | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
| JPH0676327B2 (ja) | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | ステロイド軟膏製剤 |
| JPH0676328B2 (ja) * | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | ステロイドクリ−ム製剤 |
| JPH07116026B2 (ja) | 1987-07-07 | 1995-12-13 | 株式会社資生堂 | ジクロフェナックナトリウム含有乳化外用剤 |
| AU6974191A (en) * | 1989-12-20 | 1991-07-18 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| CA2051621C (en) | 1990-03-02 | 2001-06-05 | Shiseido Company, Ltd. | Oil-in-water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug |
| TW218849B (US20080070878A1-20080320-C00003.png) * | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| US5326566A (en) | 1991-05-17 | 1994-07-05 | Bristol-Myers Squibb Company | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| EP0610401A1 (en) * | 1991-10-29 | 1994-08-17 | Audio Authority Corporation | Apparatus and method for interconnecting electronic products |
| JP4387463B2 (ja) | 1997-02-20 | 2009-12-16 | アラーガン、インコーポレイテッド | タザロテンおよびコルチコステロイドによる乾癬の処置 |
| US5972920A (en) * | 1998-02-12 | 1999-10-26 | Dermalogix Partners, Inc. | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
| SE9800729L (sv) | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | Ny topikal formulering I |
| US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| GB9823036D0 (en) | 1998-10-22 | 1998-12-16 | Glaxo Group Ltd | Fluticasone lotion having improved vasoconstrictor activity |
| WO2000040250A1 (fr) * | 1999-01-06 | 2000-07-13 | Taisho Pharmaceutical Co.,Ltd. | Lotion a base d'amelometasone |
| AU2877800A (en) | 1999-02-12 | 2000-08-29 | Susan Bershad | Short contact treatment of psoriasis with topical retinoids |
| DK1194109T3 (da) | 1999-06-25 | 2004-10-25 | Durham Pharmaceuticals Ltd | Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf |
| US6479058B1 (en) | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| US6579512B2 (en) * | 2001-06-15 | 2003-06-17 | Crutchfield, Iii Charles E. | Topical steroid spray |
| US6709663B2 (en) | 2001-08-31 | 2004-03-23 | Healthpoint, Ltd. | Multivesicular emulsion drug delivery systems |
| ES2298438T3 (es) * | 2001-12-21 | 2008-05-16 | Rhodia Inc. | Composiciones estables combinadas de tensioactivos cationicos y anionicos. |
| US6765001B2 (en) | 2001-12-21 | 2004-07-20 | Medicis Pharmaceutical Corporation | Compositions and methods for enhancing corticosteroid delivery |
| US20060018937A1 (en) | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7544674B2 (en) | 2002-10-25 | 2009-06-09 | Galderma S.A. | Topical skin care composition |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| JP2004359585A (ja) | 2003-06-03 | 2004-12-24 | Medorekkusu:Kk | 被膜形成型の副腎皮質ステロイド薬含有外用製剤 |
| US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
| US8449867B2 (en) * | 2004-08-31 | 2013-05-28 | Stiefel Research Australia Pty Ltd | Microemulsion and sub-micron emulsion process and compositions |
| WO2006098353A1 (ja) | 2005-03-15 | 2006-09-21 | Kyowa Hakko Kogyo Co., Ltd. | 外用剤 |
| US20060239929A1 (en) | 2005-04-25 | 2006-10-26 | Dow Gordon J | Use of a clobetasol spray formulation to treat psoriasis |
| CA2632616A1 (en) | 2005-12-09 | 2007-06-21 | Nycomed Us Inc. | Topical glucocorticosteroid formulations |
| CA2633464A1 (en) | 2005-12-14 | 2007-09-07 | Zars Pharma, Inc. | Compositions and methods for dermal delivery of drugs |
| PT2494959E (pt) | 2006-07-05 | 2015-02-20 | Foamix Pharmaceuticals Ltd | Veículo formador de espuma de ácido dicarboxílico e suas composições farmacêuticas |
| EP2097065A2 (en) | 2006-11-29 | 2009-09-09 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| US20100323998A1 (en) * | 2007-08-06 | 2010-12-23 | Glenmark Pharmaceuticals Ltd. | Topical composition containing the combination of mupirocin and beclomethasone |
| MX2010002592A (es) | 2007-09-10 | 2010-03-30 | Glenmark Pharmaceuticals Ltd | Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides. |
| WO2009084020A2 (en) | 2007-10-18 | 2009-07-09 | Glenmark Pharmaceuticals Limited | Topical composition comprising halobetasol and salicylic acid |
| BRPI0914630A2 (pt) | 2008-06-26 | 2019-09-24 | Anterios Inc | liberação dérmica |
| WO2010039251A1 (en) * | 2008-10-03 | 2010-04-08 | Nexmed Holdings, Inc. | Stabilized composition for treating psoriasis |
| US20100249060A1 (en) * | 2009-02-23 | 2010-09-30 | Smith Jan G | Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
| WO2010096868A1 (en) | 2009-02-25 | 2010-09-02 | Stiefel Research Australia Pty Ltd | Topical foam composition |
| US20130310355A1 (en) | 2009-12-15 | 2013-11-21 | Young Pharmaceuticals, Inc. | Low toxicity topical active agent delivery system |
| WO2012051614A2 (en) | 2010-10-15 | 2012-04-19 | Kulesza John E | Delivery of hydrophobic bioactive agents |
| US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| US20140112959A1 (en) | 2012-10-18 | 2014-04-24 | MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite | Topical steroid composition and method |
-
2011
- 2011-11-02 US US13/287,176 patent/US8809307B2/en active Active
- 2011-11-09 BR BR112013012476-8A patent/BR112013012476B1/pt active IP Right Grant
- 2011-11-09 CA CA3055328A patent/CA3055328C/en active Active
- 2011-11-09 PL PL11850419.0T patent/PL2643002T3/pl unknown
- 2011-11-09 HR HRP20230032TT patent/HRP20230032T1/hr unknown
- 2011-11-09 KR KR1020137016271A patent/KR20140043044A/ko active Search and Examination
- 2011-11-09 NZ NZ610659A patent/NZ610659A/en unknown
- 2011-11-09 EP EP22215648.1A patent/EP4233838A3/en active Pending
- 2011-11-09 WO PCT/US2011/059861 patent/WO2012087443A1/en active Application Filing
- 2011-11-09 KR KR1020187002956A patent/KR101967121B1/ko active IP Right Grant
- 2011-11-09 PT PT118504190T patent/PT2643002T/pt unknown
- 2011-11-09 AU AU2011345240A patent/AU2011345240B2/en active Active
- 2011-11-09 SI SI201132078T patent/SI2643002T1/sl unknown
- 2011-11-09 HU HUE11850419A patent/HUE061270T2/hu unknown
- 2011-11-09 LT LTEPPCT/US2011/059861T patent/LT2643002T/lt unknown
- 2011-11-09 EP EP11850419.0A patent/EP2643002B1/en active Active
- 2011-11-09 JP JP2013539894A patent/JP6111007B2/ja active Active
- 2011-11-09 MX MX2013005764A patent/MX346961B/es active IP Right Grant
- 2011-11-09 CA CA2817524A patent/CA2817524C/en active Active
- 2011-11-09 RU RU2013128607/15A patent/RU2568598C2/ru active
- 2011-11-09 CN CN201180056051.0A patent/CN103228281B/zh active Active
- 2011-11-09 ES ES11850419T patent/ES2935814T3/es active Active
-
2013
- 2013-05-16 IL IL226398A patent/IL226398B2/en unknown
-
2014
- 2014-07-24 US US14/340,367 patent/US11213587B2/en active Active
-
2017
- 2017-06-06 US US15/615,752 patent/US10478502B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX346961B (es) | Formulaciones farmaceuticas que contienen corticosteroides para la administracion topica. | |
| MX340591B (es) | Formulaciones de liberacion inmediata y formas de dosis de gamma-hidroxibutirato. | |
| EP4342546A3 (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| MX2016013693A (es) | Crema transdermica. | |
| MY188598A (en) | Dexmedetomidine premix formulation | |
| MX2019007956A (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| MX358344B (es) | Composiciones farmaceuticas que comprenden un antipsicotico insoluble en agua y esteres de sorbitan. | |
| PH12014502778A1 (en) | Antibody formulation | |
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| MX2014008284A (es) | Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta. | |
| MX352328B (es) | Formulaciones orales de ester de testosterona y metodos para el tratamiento de la deficiencia de testosterona que comprende estos. | |
| MX351584B (es) | Formulacion farmaceutica acuosa de tapentadol para administracion oral. | |
| MX2014008283A (es) | Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta. | |
| NZ631833A (en) | Emulsion formulations | |
| EP2823819A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING OLEANOLIC ACID ACETATE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MEDIATED DISEASE BY TLR OR IL-6 | |
| BR112013020167A2 (pt) | melhoradores de permeação para formulações tópicas | |
| NZ718163A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| MX2016011290A (es) | Composiciones de ester de colina de acido lipoico y metodos de uso. | |
| IN2014CN03214A (US20080070878A1-20080320-C00003.png) | ||
| NZ702342A (en) | Pharmaceutical formulation | |
| MX2009009838A (es) | Esteres de acidos grasos de glucocorticoides como agentes antiinflamatorios y anti-cancer. | |
| GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| MX2014001065A (es) | Formulaciones de (trimetoxifenilamino) pirimidilino nuevas. | |
| MY171526A (en) | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | |
| IN2014MN02156A (US20080070878A1-20080320-C00003.png) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |